Purpose

The main purpose of this study is to determine whether people who participate in MiWeigh lose more weight than people who receive information about weight loss strategies and programs. The researchers also want to learn what parts of the program do and do not work and why. If the program is effective, the researchers want to learn how other health care systems could offer this program. The overarching aim of the MiWeigh Study is to better help patients prevent, manage, or reverse obesity-related chronic conditions.

Condition

Eligibility

Eligible Ages
Between 18 Years and 75 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Body Mass index (BMI) 30 kilogram per square meter or higher - Diagnosed with one or more of the following weight-related conditions: - Type 2 Diabetes - Prediabetes Mellitus - Hyperlipidemia (HLP) - Hypertension (HTN) - Polycystic Ovary Syndrome (PCOS) - Obstructive Sleep Apnea (OSA) and/or - Metabolic dysfunction-associated steatotic liver disease (MASLD) - Speaks English - Interest in losing weight - Willingness to complete assessments per study protocol - Willing and able to use the Electronic health records patient portal to respond to messages - Willing to report weight weekly by text if randomized to intervention arm - Able to see provider virtually at certain days/times up to four times in a year

Exclusion Criteria

  • ≥ 5% weight loss within the prior 12 months - Has had a Weight Navigation Program visit in past - Pregnant, planning a pregnancy, or breastfeeding in the next year - Ongoing participation in another weight-loss program - Taking an anti-obesity medication - Ever diagnosed with Type 1 Diabetes Mellitus (per protocol) - Dementia - Serious uncontrolled mental health conditions as indicated (per protocol) - Chronic kidney disease, Stage 4 or higher - Alcohol dependence and opioid dependence (per protocol) - History of anorexia or bulimia - Bariatric/ gastric bypass surgery, gastric sleeve surgery, or gastric balloon procedure in last year - Currently enrolled in an interventional research study that is examining how a diet, program, or drug might: promote physical exercise, healthy eating habits, or weight loss; lower blood pressure; or lower blood sugar - Not planning to live in local area over the next year - Intensive cancer treatment such as bone marrow transplant, chemotherapy, radiation, or cancer related surgery (not including hormonal chemotherapy like Tamoxifen) in last six months or next 12 months - Other serious health issues or personal concerns that could prevent participant from completing study

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)
Masking Description
Outcome assessors will be blinded.

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
MiWeigh
  • Behavioral: MiWeigh
    Participants will complete a baseline assessment that includes a survey, blood draw, and body measurements. Participants will be given access to a website with information on weight-loss options and have at least one visit with a doctor that has special training in obesity medicine. Prior to this visit, clinical pre-surveys and additional laboratory blood tests will be completed. During this visit, the doctor will work with the participant to develop an individualized weight-loss treatment plan. Additionally, participants will report weight weekly via text and receive periodic supportive messages via the health portal or phone call.
Active Comparator
Enhanced Usual Care
  • Behavioral: Enhanced Usual Care (EUC)
    Participants will complete assessments at baseline and 12 months that include a survey, blood draw, and body measurements, plus a survey at 6 months. Once randomized, participants will be given access to a website with information on weight-loss options and advised to see their primary care provider if a participant wishes to discuss the options.

Recruiting Locations

University of Michigan
Ann Arbor, Michigan 48109
Contact:
Shelley Stoll, MPH
734-232-0697
scstoll@med.umich.edu

More Details

Status
Recruiting
Sponsor
University of Michigan

Study Contact

Shelley Stoll
734-232-0697
scstoll@med.umich.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.